Ex Vivo Drug Screening and Genomics Profiling to Guide Treatments for Children with Relapsed or Refractory Solid Tumors and Leukemia

Identification of Therapeutic Targets and Pathways in Relapsed Childhood Acute Lymphocytic Leukemia (ALL) Associated with NSD2 Mutations

Pharmacogenomics and Toxicities of Thiotepa, Busulfan, and Fludarabine in Pediatric HSCT Recipients

Molecular Basis and Treatment of Pediatric AML with Hyperexpression of EVI1

Designing New Strategies for Most Lethal Forms of Medulloblastoma

Maintaining Renal Function After Total Body Irradiation

Anti-Neuroblastoma Effects of ICA-1

Enhancing Immunotherapy Through Inhibition of CAIX to Treat Osteosarcoma